• 1: Home
• 2: About Macsmith
  • 2.1: History
  • 2.2: Johnson Matthey PLC
  • 2.3: Fine Chemicals Division
  • 2.4: Corporate Governance
  • 2.5: Corporate Social Responsibility
  • 2.6: Sustainability 2017
  • 2.7: Health and Safety
  • 2.8: Charitable Work
  • 2.9: Ethical Policy
  • 2.10: Macsmith links
• 3: News & Events
  • 3.1: Upcoming events
• 4: Products and Services
  • 4.1: Product list
  • 4.2: Bulk production
  • 4.3: SSM
  • 4.4: Extractive technologies
  • 4.5: Chemical and analytical development
  • 4.7: Bitrex - Denatonium Benzoate
  • 4.8: Regulatory
  • 4.9: Poppy Growing
• 5: Secure area
  • 5.2: Login / Register
• 6: Careers
  • 6.1: Current Vacancies
  • 6.2: Working for Macsmith
  • 6.3: Graduates
  • 6.4: Placements
  • 6.5: Training and development
• 7: Useful Resources
  • 7.1: Brochures
  • 7.2: Worldwide Partners

The Johnson Matthey group continued to make further good progress in the third quarter. Compared with the same period last year, sales excluding precious metals (sales) were up 22% at £649 million and underlying profit before tax increased by 34% to £104.3 million.

The Fine Chemicals Division continued its strong performance with sales up 15% to £62 million and good growth in operating profit. The Active Pharmaceutical Ingredient (API) Manufacturing businesses performed well aided by sales of a new API for the treatment of drug addiction.

For further information, please click here.